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Dirofilaria immitis is a common and largely preventable mosquito-borne parasite that causes 
dirofilariasis, or heartworm disease, in a number of animal species. The necessity of heartworm 
prevention in the canine patient is undisputed and well-known among veterinary professionals, 
yet there are still many dogs not protected from this fatal parasite. Heartworm prevention 
traditionally requires a once-a-month administration of medication; therefore, its efficacy relies 
on owner compliance. The barriers to canines receiving heartworm prevention were assessed 
using a survey targeted at pet owners whose dogs have seen the veterinarian in the past year. 
The main barriers identified were inadequate client communication and understanding, 
expense of prevention, and forgetfulness. The goal of this research is to establish the barriers to 
pets receiving monthly heartworm prevention so that veterinary professionals can be made 
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The topic of heartworms and heartworm prevention is part of daily conversation for a 
general practice veterinarian and their staff. A veterinary professional may talk with clients 
about this disease upwards of ten times a day, but according to a 2019 study only 25% of dogs 
are actually on consistent heartworm prevention (Johnson and Padgett.) Clients want to keep 
their pets happy and healthy, and veterinarians want to help pet owners do just that. There are 
so many diseases that even the best veterinarian cannot prevent or even treat, but heartworm 
disease is not one of them. Recommending and giving heartworm prevention is a simple way to 
prevent heartworms and keep pets healthy. So why are only 25% being protected from this 
disease?  
There is a disconnect between the scientific evidence that heartworm prevention is 
necessary and what really happens when the pet leaves the vet clinic. In veterinary medicine 
there is an intermediate between doctor recommendations and the care that the patient 
receives: the client, or pet owner. It is the job of the veterinary professional to give clients the 
tools they need and empower them to be an active part in their pet’s health. This research will 
seek to identify the barriers to pets receiving heartworm prevention so that veterinary 
professionals can address the barriers to better serve clients and prevent as many pets as 
possible from contracting this fatal parasite. The barriers investigated will mainly focus on the 
communication between the veterinary professional and the client, but also include factors 






Heartworm disease is a serious, life-threatening disease caused by infection with 
Dirofilaria immitus, a parasitic worm. The canine patient is a definitive host for this parasite and 
the pulmonary artery is its preferred final destination. The life cycle for this parasite begins 
when any of up to seventy mosquito species draws a blood meal from an animal infected with 
heartworms (Aiello and Moses 127.) The mosquito ingests larval stage 1 (L1) of the parasite, 
known as microfilaria. The parasite matures from L1 to L3 in the mosquito over a period of 10-
30 days and migrates from the gut to the mouth parts (Barnette and Ward.) L3 is considered 
the infective stage of Dirofilaria immitus, at this stage the mosquito can infect a canine through 
a bite. Once a patient is infected, within 3-9 days the parasite matures to stage L4 in the 
subcutaneous tissue and migrates through the tissues and muscle fibers. The parasite molts 
one last time between day 50 and day 70 as they migrate through the body into the circulatory 
system. These immature adults can reach the pulmonary vasculature as early as day 67 
(American Heartworm Society [AHS] 9-10.) The worms mature in the pulmonary arteries and 
can reach up to 12 inches in length (AHS 10.) Once the female worm is sexually mature, she will 
begin to release microfilaria, or larval stage 1. Microfilaria can be detected in the blood of an 
infected patient as early as six months after infection. From this point on this patient is a danger 
to other dogs as mosquitos can become infected from feeding on the patient and begin the 
cycle once again, infecting animals up to one hundred miles away. The American Mosquito 
Control Association states that most species of mosquitos have flight ranges of one to three 
miles, but some have been known to migrate up to one hundred miles. Microfilaria may survive 
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for up to two years in the patient waiting for the mosquito to arrive and become the 
intermediate host but left untreated the adult worms will continue to produce new microfilaria 
(Aiello and Moses 128.)  
Clinical Signs 
The presence of heartworms in the canine heart is disruptive to the natural physiology 
of the body, and this manifests through many different clinical signs. The worms initially live in 
the pulmonary arteries, but as their size and numbers grow, they can invade the right ventricle, 
right atrium, and even the vena cava (AHS 10.) Adult worms typically live for three to five years 
in the patient and during that time they are altering the normal function of the heart (Aiello and 
Moses 128.) Merck Veterinary Manual states “Live adult heartworms cause direct mechanical 
trauma, and other suspected factors (eg, antigens and excretions) are thought to directly 
irritate or stimulate the hosts’ immune system to damage vessel intima…. the presence of dead 
worms leads to more severe vascular reactions and subsequent lung pathology…” (Aiello and 
Moses 128.) The residence of the worms in the heart and the damage they inflict there can 
cause clinical signs in other areas of the patient. Barnette and Ward list the most obvious 
clinical signs of heartworm disease as a soft, dry cough, shortness of breath, weakness, 
listlessness, and loss of stamina. Unfortunately, by the time these clinical signs are noticed the 
parasites have already done permanent damage to the heart muscle. 
Parasite presence in the heart causes the heart to work harder to contract, resulting in 
hypertrophy of the muscle and eventual decrease in the blood flow out of the heart and 
increased pressure. If the disease is far enough progressed this heart enlargement is significant 
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enough to be seen on radiographs. This heart enlargement puts pressure on and can even 
displace the trachea dorsally, this pressure is the cause of the signature cough associated with 
heartworm disease. The patient experiences weakness and loss of stamina due to the increased 
workload on the heart to perform its function. If the heart is already struggling to meet 
demands when the patient is at rest, it’s inadequacy will become apparent with exercise. The 
patient will have an increased respiratory rate and a decreased activity level. Shortness of 
breath occurs when the ability of the heart to pump blood to the lungs is compromised. The 
presence of the worms impedes the natural blood flow of deoxygenated blood from the right 
side of the heart to the lungs. This back-up of blood can also cause ascites, or a buildup of fluid 
in the abdomen. At this point, the heart has begun to fail.  
Unfortunately, when the disease has progressed to heart failure there is little to be done 
to improve the quality of life for the patient or the time they have left. When a client brings 
their pet to the veterinarian with symptoms such as cough, exercise intolerance, and ascites the 
damage to the heart is extensive and permanent which means only the symptoms can be 
managed. It takes years for heartworm disease to progress to this stage; when caught early 
through annual heartworm testing, there is a conversation to be had about treating the 
heartworms to prevent heart failure and the symptoms associated with it.  
Testing 
The American Heartworm Society recommends annual heartworm testing for all canines 
regardless of clients’ compliance with heartworm prevention. There are several reasons why a 
patient on heartworm prevention may still contract heartworms including forgotten or late 
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doses, or a patient vomiting or rubbing off prevention. Even with perfect heartworm prevention 
compliance there is still a small chance of infection with prevention-resistant parasites. An 
annual heartworm test ensures that the disease can be caught in its earliest stages to discuss 
treatment options before permanent damage is done. Additionally, a patient should be tested 
before beginning heartworm prevention if their history on prevention is unknown or 
inconsistent. Starting a patient with a high parasite load on heartworm prevention can cause 
dangerous side effects, therefore the risks should be assessed and discussed with the client 
before beginning prevention.  
There are two broad types of heartworm tests: antigen testing with an enzyme-linked 
immunosorbent assay (ELISA) test and microfilaria testing, most commonly performed by 
examining a blood sample under the microscope. The American Heartworm Society 
recommends both an antigen and microfilaria test be performed annually due to the possibility 
of both tests giving false negatives in unique circumstances (16.) The ELISA test is the most 
sensitive and tests for the presence of the adult heartworms themselves through detection of 
an antigen produced by the adult female parasite, but antigen-antibody complexes can cause 
false negative results (AHS 16.) The ELISA test is the most used for annual testing of 
asymptomatic patients and when seeking a result for a suspected positive patient (Aiello and 
Moses 130.) The microfilaria testing can give a false negative result because about twenty 
percent of positive patients are not microfilaremic, and that figure is higher for patients on 





Heartworm “treatment” can mean a variety of different things and employ different 
drugs and protocol, but generally refers to the administration of an adulticide, a medication 
that kills adult heartworms. The recommended treatment plan can vary based on the patient’s 
symptoms (or lack thereof) and other factors such as age and activity level. The only adulticide 
approved for heartworm treatment is melarsomine dihydrochloride. Merck Veterinary Manual 
states that melarsomine is given at a 2.5mg/kg dose intramuscularly in the epaxial musculature 
in the area of the third to fifth lumbar vertebrae (133.) This drug is an arsenic containing 
compound and carries the risk for side effects from local reaction at the injection site to sudden 
death caused by a pulmonary thromboembolism. A pulmonary thromboembolism occurs when 
a piece of dead heartworm dislodges into circulation and causes a blockage in the lungs. The 
risk of this deadly occurrence can be reduced by strictly reducing activity and excitement of the 
patient through methods such as cage rest and leash walking to use the bathroom.  
Melarsomine is often given in conjunction with other medications the most common of 
which being doxycycline and prednisone. Doxycycline is given to kill Wolbachia pipiens, a 
bacterium necessary for normal maturation, reproduction, and infectivity of the heartworm. If 
Wolbachia are killed the adult heartworm gradually dies (Aiello and Moses 128.) Prednisone 
helps control the clinical signs of pulmonary thromboembolism during treatment. The following 
table shows the American Heartworm Association recommended protocol for the treatment of 
adult heartworms.  
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Figure 1 (AHS 25) American Heartworm Association recommended protocol for the 
management of adult heartworms. 
Some patients are simply not a candidate for treatment due to the toll it takes on the body such 
as geriatric patients and those with advanced disease. The risk for severe and deadly side 
effects of the melarsamine injections significantly increases in patients who are exhibiting 
symptoms such as a cough. Additionally, treatment may not be an option due to the financial 
constraints of the client. The AHS states that the average cost of treatment for a forty-pound 
dog is between $1,200 and $1,800 including all medications and diagnostics. The patient’s 
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veterinarian may recommend a variation of the mentioned medications and protocol to fit the 
patient’s individual circumstances. One of the alternative methods is the long-term use of 
heartworm prevention to kill the adult heartworms slowly over time.  
The slow kill method of treatment is not recommended by the AHS but is an intermediate 
between the “gold standard” of care and no treatment at all. The clients budget often plays a 
large role in the use of this method. In this approach monthly ivermectin with or without 
doxycycline and prednisone is given and will shorten the lifespan of the adult heartworm. Most 
notably, the adulticide melarsamine is not used in this method. According to the AHS it has 
been shown to take over two years for the adult heartworms to die using this method (30.) 
During that time the disease is progressing as the worms are still causing damage to the heart 
muscle. Additionally, these patients continue to serve as a vector for the parasite because the 
adult heartworms are still reproducing and releasing microfilaria into circulation to be ingested 
by a mosquito. It is also mentioned that this method contributes to resistant subpopulations of 
heartworms (AHS 30.) 
Prevention 
There are many different drugs and brand names classified as heartworm prevention, 
but all of them are in the same class of macrocyclic lactones and serve the same purpose: kill 
heartworms and their life stages. Heartworm prevention kills all stages of the parasite except 
L2, which resides only in the mosquito. However, as mentioned, the prevention alone can take 
years of consistent use to kill L6, or adult heartworms. The intended use of heartworm 
prevention is to kill L3 as soon as it enters the patient via a mosquito bite before it has time to 
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mature and cause harm to the patient. Heartworm preventative will protect against L3 and L4 
stages for the time period that it is labeled for, beyond that time period protection is 
unpredictable.  
Prevention-resistant parasites have been recognized; however, “lack of efficacy” events 
are better explained by other causes such as failure to administer the prevention at the proper 
dose and frequency and failure of sufficient absorption of the active ingredient due to emesis 
(AHS 10.) A study conducted to review patients that tested positive for heartworm antigen 
while on heartworm prevention found that 80.7% of these patients had a gap in administration 
of prevention. Only 1.7% of cases had no purchase gaps and no factors that could influence or 
indicate insufficient administration of heartworm preventive (Atkins et al 109.) While resistance 
has been identified, it is not common. Macrocyclic lactones are highly effective and one of the 
safest medications used in veterinary medicine when administered according to label 
instructions (AHS 9.) 
Clients have several routes of administration to choose from for their dogs’ heartworm 
prevention: topical, oral, and parenteral. Oral preventatives are designed for the patient to eat 
freely when given; they are often in the form of a chew and contain a flavor additive to aid in 
palatability of the medication. The somewhat recent addition of an injectable option 
administered by a veterinarian allows clients who may not be able to administer medication to 
their pet a safe, effective option for heartworm prevention. Additionally, the injectable form 
comes in a six-month and twelve-month formulation relieving the client of a monthly 
responsibility. However, this convenience comes at a cost that not all pet owners can afford; 
many clients still elect a monthly preventative. 
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For the most part, veterinarians see healthy patients once a year. The client brings their 
pet in for an exam and vaccinations, and they are mentally “checked off” for an entire year. In 
one visit that may last fifteen minutes veterinary staff must impress the importance of 
heartworm prevention on the client well enough for them to make it a point to give their pet 
prevention every thirty days. To prevent this disease, clients must take their pets health into 
their own hands when the veterinary staff is no longer there. Clients must see the value in 
giving the prevention both to carry out the proper administration and to justify the cost of the 
prevention.  
Not only must we impress upon the client the necessity of monthly heartworm 
prevention, but also the need for annual heartworm testing at an additional expense. The 
nature of the disease is such that no symptoms will be noticed until extensive permanent 
damage has been done. It is difficult for all parties involved to find out that a pet has a fatal 
disease that was completely preventable and could have been treated if caught early. When the 
disease is caught early through annual testing treatment is still extensive, expensive, and 
difficult on the pet. The best situation is for canine patients to receive consistent, veterinarian 
recommended heartworm prevention twelve months out of the year.  
There are many factors involved as to why pets do not receive heartworm prevention 
and annual testing. These factors will be explored using the results of a survey targeted at dog 
owners whose pets have seen a veterinarian in the past year. Once identified, veterinary 
professionals can seek to find more ways to support pet owners in protecting their dogs from 
this disease.  
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Methods and Procedures 
The scientific evidence of heartworm life cycle, disease, and prevention has been laid 
out to show the indisputable fact that consistent, veterinarian recommended heartworm 
prevention is medically necessary for canine patients. This research seeks to find the barriers to 
pets receiving this medication through a survey targeted at pet owners, the individuals 
responsible for purchasing and administering heartworm prevention. The target of the survey 
was clients whose pets have been seen by a veterinarian in the past year due to the fact that 
heartworm prevention is a prescription medication that requires an exam by a veterinarian. The 
hypothesis is that the clients whose pets who do not receive heartworm prevention are simply 
unaware of its necessity or confused about which products to use and their administration, thus 
leading one to believe the issue lies in the communication between veterinary professionals 
and clients.  
The survey was approved by the Murray State Institutional Review Board and was 
estimated to take no longer than ten minutes to complete. Participants were made aware of 
their rights to decline to answer questions or leave the survey entirely once beginning as well as 
a reasonable assurance of confidentiality. The survey consisted of multiple choice, open 
response, and select all that apply questions as well as an opportunity to add any additional 
thoughts. At the close of the survey a statement advising participants to contact their 
veterinarian with any questions regarding their pets’ health was included. The Google Forms 
survey and participation consent can be found in the appendices.  
12 
 
The survey was disseminated in an online format through Facebook with the title 
“Barriers to Client Compliance and Understanding of Heartworm Prevention in the Canine 
Patient.” A flier with a link to the survey was also advertised in various pet-related businesses 
and parks. The survey was available to the public for three weeks. Due to the nature of the 
primary investigators circle of peers a larger than average number of respondents were 
formally educated or employed in the field of veterinary medicine. This is acknowledged as 
causing somewhat of a bias in results; however, these responses can be separated and analyzed 
independently due to a specific yes or no question about formal education or employment in 
the field of veterinary medicine. It is also acknowledged that results will be skewed due to the 
title of the survey indicating its subject matter of heartworm prevention. Potential participants 
uneducated in this matter may have chosen not to respond due to their lack of knowledge 
and/or interest. The percentage of pets receiving heartworm prevention may be inflated, but 
the information regarding barriers should provide a reasonably full picture.  
Results 
The survey received one hundred and seventeen responses in the twenty-five days it was 
available. The participants represented the care of two hundred and twenty-eight canines. All 
participants were the primary caretaker of at least one dog, and 99.1% of those participants 
owned dogs over the age of six months. Due to the overwhelming majority of canines 
represented being over 6 months, the results will not be skewed by patients who are too young 
to receive prevention. It is noted that the one participant with a young dog indicated that they 
had already started giving prevention and planned to continue as prescribed. 
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Over 99% of participants indicated that a veterinary professional had spoken with them 
about heartworm prevention. The most common professional to speak with clients about 
heartworm prevention was the veterinarian at 95.6% followed by the technician and 
receptionist at 41.6% and 14.2% respectively. Figure 1 shows how well the client understood 
what was being discussed.  
 
 
Figure 2. Pie charts reflecting the responses of participants when asked to identify how well 
they understood why heartworm prevention was recommended as well as understanding of 
when and how to give prevention. 
14 
 
The percentage of participants that indicated anything other than the correct answer of 
once monthly or every thirty-day administration when asked how often oral/topical prevention 
should be given was 15.7. This question received only 102 answers out of the 117 participants. 
A majority (67.5%) of participants indicated the importance of heartworm prevention as a ten 
out of ten. The full spread of responses can be seen in Figure 3.  
Figure 3. Bar graph showing the number of responses from zero to ten when participants 
were asked to rank how important giving heartworm prevention is. 
All participants answered the question “Is your dog(s) on heartworm prevention,” 83.8% 
indicated “yes” and zero participants responded “unknown.” If one were to exclude all 
responses from participants formally educated or employed in the field of veterinary medicine 
the percentage of “yes” responses would be slightly lower at 82.1%. Seventy-four percent of 
participants indicated that they strive to give prevention year-round and 10.4% strive to give it 
only during the warm months of the year. One participant indicated that they strive to give 
prevention once every three months, and the remaining responses indicated that they do not 
give any prevention. Figure 4 indicates how many months out of the year participants actually 
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manage to give prevention. The majority of participants indicated that they give prevention 
twelve months out of the year. 
 
Figure 4. Pie chart reflecting how many months out of the year participants administer 
heartworm prevention. Colors light purple, dark blue, and red represent eleven, ten, and nine 
months respectively. 
Participants who do not give any heartworm prevention were asked to identify a reason, 
twenty-three responses were collected. Finances was a factor for 34.7% of respondents, 30.4% 
used their pet’s low likelihood of infection as rational, and 13% indicated that they do not 
believe prevention is effective at preventing heartworms. Each of the following sentiments was 
indicated by at least one participant: heartworm prevention is deadly, forgetfulness, and not 
having time for a veterinary appointment. A total of thirty-nine responses were collected from 
the question asking participants who give some prevention but not 12 months out of the year 
to indicate why. This was a select all that apply question. One third of participants said they did 
not believe prevention was necessary in the winter/cooler months and an additional one third 
said they forget to give prevention. Twenty point five percent of participants indicated that 
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they forget to buy prevention, 5.2% indicated expense, and 2.6% said it was because their pet 
rarely goes outside. 
 
 
Figure 5. Pie charts reflecting participant responses regarding annual heartworm testing and 
rational for lack of testing. 
When asked to explain why they declined the annual heartworm test the overwhelming 
majority listed that they did not believe it was necessary if their pet was on year-round 
prevention. There were two responses that mentioned cost and risk factor. 
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When participants were asked if they would like more information on heartworms and 
how to protect their dog 86.5% indicated “no.” Below in figure 5 are the parting thoughts of 
participants that the investigator deems relevant to the research. For the sake of transparency 
all spelling and grammatical errors are included. 
Would you like to add anything? 
I don’t think that it’s stressed nearly enough to clients that most prevention needs to be 
given regularly and on the same day every month. I am a vet tech major which is how I know 
that, but I didn’t know it before I entered this program. I also don’t think there’s enough 
emphasis on needing to do it year round, or at least there wasn’t by my vet that i take my 
dogs to. 
 
My dog had heart worm while taking a heart worm preventative. 
 
Do the research before giving any heartwork or flea and tick prevention. It may save your 
dogs life. These are insecticides you are feeding your babies. 
 
For years I gave the monthly meds, no heartworm. Then I quit since dogs are inside dogs, 
and for years now, no heart worm. That makes me question whether the meds are necessary 
for indoor mostly dogs. 
 
I found even if I gave heartwork pills to my dog every month he still has to be tested to see if 
he has it. That makes no sense. He was taking all year long n being tested. Just to get money 
for test. Prices of both pills n test should not be so expensive n people would get more often. 
It’s just too expensive!!! 
 
When I have issued in the past it has been for just not remembering or running out of meds. 
I wish the vet would like send me reminders texts about the meds. It's not thier 
responsibility, but it would be nice it there was like a automated system to prompt me.  
 
We love our dog very much, however, going to the vet is expensive so we choose to take 
care of him best we can and pay our doctor visits instead. Sad but true 
 
The best conversation I had was when the vet said “using ours allows liability coverage, if he 
gets heart worms we would cover it through the medical provider” - however it can seem 
like just another overused sales pitch for some. I know I paid $250 more for a neuter once 
with all the “additional testing” plus my vet requires a $50+ exam fee even if my dog doesn’t 
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get all the exams. I don’t blame people for thinking heart worms are just another thing to be 
overcharged for 
 
It is difficult to get my veterinarian to fax a prescription to online pharmacy. They refuse.  
 
There are cheaper methods than listed 
 
Unfortunately multiple things that aid in the animals general health are not available without 
a vet. Adding larger costs for something that should be more adorable if it was the animals 
well being not the vets well being in mind. 
 
Since Covid, the vet tech comes to the car to get the dog. I have minimal to no interaction 
with the vet 
 
Make it OTC 
 
Some heartworm preventative is not working the way it should. For example heart guard is 
known in the vet world to be one of the preventatives that dogs are coming back positive 
even if they have been on it for years. 
 
Thank you for doing the survey! Heartworm is a horrible, preventable illness that more 
owners should be aware of. I have always had Great Danes and made sure they got their 
monthly dose. 
 
I asked my vet but they said it’s not a concern, I’m in Southern California- that may explain it 
 
My daughter took in a dog that heart worms. We learned a lot at that time about it. 
Although prevention is costly so is the treatment. Luckily it’s been 7 years and he’s st ill going 
strong. The treatment saved his life. 
 
I had a dog I adopted from the island of Antigua where nearly every dog has heartworms. 
She was positive. Luckily there was no obvious damage and she was able to be treated once 
in the states. Treatment is very expensive and it’s hard on dogs. It was sad not to see her be 
able to run for quite a while. I wanted to share my own experience of having a heartworm 
positive dog and going through treatment. 
 
Would like to know other opinions about heartworm protection in our state of AZ 
 
Figure 6. Direct, unedited feedback from participants at the end of the survey. Comments not 





The hypothesis was that the lack of heartworm prevention use is due to lack of 
communication between the client and veterinary professional both on the overall discussion 
of heartworm existence and the clients understanding of the large risk they can pose to their 
pets’ health. The overwhelming majority of participants (96.6%) had been educated by a 
veterinary professional and, as figure 1 shows, a relatively low number of participants did not 
agree with the statement of understanding why prevention was being recommended and 
how/when to administer it at 11.1% and 7.7% respectively. However, there is a disconnect 
between participants answer on whether or not they understood how and when to give 
prevention and the reality, which can be measured by their answer to the fill in the blank 
question of how often to give oral/topical prevention. Only 7.7% of respondents reported not 
knowing how/when to give prevention, but over double that number answered the question 
incorrectly (15.7%) and fifteen participants elected not to answer this question, leading one to 
believe that they did not know how to respond. This means it could be concluded that up to 
25% of participants did not know how often to give prevention. This indicates client confusion; 
the veterinary professional may have said one thing, but the client heard something different 
and believes their pet is fully protected, when in reality they are not.  
Eighty-three point eight participants responded “yes” they give heartworm prevention, 
but when the products they reported administering are analyzed it is seen that 20.5% of those 
respondents are only giving flea and tick prevention. Many of the participants in this category 
ranked the importance of giving heartworm prevention at a ten out of ten. These respondents 
believe that they are protecting their pet from heartworm disease, but that is not the case. This 
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leaves only about 60% of participants pets actually receiving heartworm prevention. It can be 
concluded from this data that veterinary professionals are doing an excellent job of bringing up 
the topic of heartworms to their clients, but the effectiveness of the discussion can be 
improved.  
Client confusion about how and when to give prevention can lead to misconceptions 
that heartworm prevention is not effective. When participants who do not give any heartworm 
prevention were asked for a rational 13% indicated that they do not believe heartworm 
prevention is effective. If the clients pet tests positive for heartworms they believe it was due to 
the medication being ineffective when in reality it was being administered incorrectly or not at 
all.  This begins a domino effect of miscommunication and in some instances leads the client to 
believe the veterinary practice is only sees heartworm prevention and testing as a means to 
make a profit. Evidence of this thought can be seen in figure 5.  
Ten point four percent of participants only give heartworm prevention during the warm 
months of the year. According to the data collected, about 30.4% of clients that do not give 
year-round prevention use low risk of infection as a rational. It is not clear from the data 
collected what level of understanding the clients have about their pets’ risk of infection. Many 
clients perceive their inside dogs’ risk to be low enough that the expense or inconvenience of 
prevention is not worth it, and while indoor pets’ risk may be lower than an outdoor pet, there 
is still a chance of infection.  
About one fourth of participants whose dogs do not have an annual heartworm test 
done responded that they decline the annual heartworm test. The overwhelming majority 
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indicated in short-answer format that they do not believe it is necessary if their pet is on 
heartworm prevention. As mentioned, about 20% of respondents who indicated that they give 
heartworm prevention are only giving flea and tick prevention and an additional 22.2% do not 
give prevention twelve months out of the year. The pets of these participants are left 
vulnerable to heartworm disease with or without client knowledge. Heartworm disease is not 
recognized until some degree of permanent damage has been done to the heart muscle, so 
annual testing is highly recommended.  
Analysis of the survey results revealed the following major barriers to pets receiving 
heartworm prevention: client confusion, forgetfulness, and finances. Since up to 25% of 
participants do not know when and how to give prevention and 20% believe they are giving 
heartworm prevention but are not, a large barrier to pets receiving prevention is client 
confusion. Client forgetfulness is also prevalent with 53.8% of participants indicating they forget 
to give prevention and/or forget to buy prevention on a select-all-that-apply question. Finances 
also play a role for some clients with 34.7% of participants listing it as a rational for their pet 
not receiving any prevention.  
Conclusion  
Veterinary professionals are doing an excellent job of broaching the topic of heartworm 
prevention with their clients, but survey results indicate the either the quality of the 
conversation or the level of client understanding can be improved, or both. A trip to the 
veterinarian can be stressful for pets and clients whether it is due to bad memories, the hassle 
of transporting a pet, finances, or otherwise. This stress can cause important information to be 
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missed by the client. Clients are only exposed to this onslaught of potentially overwhelming 
information one time per year. Topics can include when to spay or neuter, changes in health 
seen on physical exam, and other preventatives in addition to any concerns the client has when 
bringing their pet in. It is easy for the information about heartworm prevention to go in one ear 
and out the other. Clients should be exposed to this information in more ways than one and 
more times than once. This includes having the entire veterinary team participate in education 
from the first face they see when checking in to the technician and veterinarian.  
A study performed by Partners for Healthy Pets using five years of compiled data from 
surveys of pet owners and veterinary staff indicates that pet owners do not always understand 
what the staff believes they are communicating to them. Communication is arguably the most 
important aspect of veterinary medicine and inadequacies in this area cause many pets to go 
without prevention. The twenty percent of clients who believe they are giving prevention but 
are in fact only administering flea and tick prevention are an example of inadequate 
communication with the veterinary team. Clients should be aware of the products they are 
giving their pets and it is the veterinary professionals’ responsibility to help them navigate the 
overwhelming amount of product options to select products that are appropriate for the 
patient. Receptionists should be aware of the products that their practice carries and what 
parasites they cover so they can assist clients during checkout and educate the clients who are 
only purchasing flea and tick preventative.  
Receiving information auditorily can only go so far, especially when the amount of 
information is large, and the topic may be foreign to clients. Placing visual client education tools 
in exam rooms such as a chart displaying different types of heartworm prevention, a model 
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heart infected with parasites, or a poster with disease prevalence in the area can improve 
clients understanding and help them see how serious heartworm disease is. Another low-cost 
option to expose clients to this information is to post information or even do trivia about 
heartworms on social media pages. It may also be helpful to send clients with a pamphlet 
explaining what was discussed and that highlights important take-aways so that they are 
relieved of trying to remember everything that was said and can digest the information at a 
later time or discuss it with co-owners. The more times and ways clients receive this 
information the better they will understand and the more likely they are to remember to give 
prevention.  
It is important for veterinary professionals to remember to give clients all the 
information about why they are recommending heartworm prevention. Clients are more likely 
to comply if they understand the why behind the cost and inconvenience. It can be easy to 
simply state that prevention is recommended and once the client agrees move on to another 
topic. This same premise applies with heartworm testing, if it is offered and the client declines 
it is easiest to end the conversation there. However, veterinary professionals need to ensure 
clients understand what they are declining or why they are agreeing to give a medication. If a 
client quickly agrees to give prevention but does not understand why it is important it is much 
easier for them to discontinue use for any of the reasons mentioned such as perceived risk of 
infection, expense, or inconvenience without fully realizing the implications of their decision. If 
the veterinary professional has not discussed their pets risk level the client is left to their own 
devices to determine what they believe the risk to be. A client that agrees without being given 
all the information may purchase a dose when prompted, but never return for the next month’s 
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dose. Clients should be made aware of what end-stage heartworm disease looks like, the 
expense of treatment, and a realistic idea of their pets’ risk of infection. It is the responsibility 
of the veterinarian to make sure clients can make an educated decision about their pet’s 
health, regardless of what that decision may be.  
It is worth noting that communication between the veterinary professional and client 
was severely impeded during the COVID-19 pandemic. Many veterinary clinics were offering 
only curbside service and face-to-face interaction was strictly limited. This period lasted for a 
minimum of six months and up to over a year for some locations. New pet owners may have 
missed a critical period in forming a relationship with their veterinarian. Most communication 
during this time was happening over the phone which is inhibitory due to the loss of non-verbal 
cues. Since keeping a distance from clients was a necessity during this time, important 
information such as the heartworm prevention discussion may have been missed. This lapse of 
in-person communication heightens the need to discuss heartworm prevention with all canine 
owners regardless of the number of previous visits or assumed knowledge. Many clients still 
elect to continue curbside veterinary services either for safety or convenience. Veterinary 
professionals should be ensuring that these clients are still receiving the same level of 
education that would be given in an exam room.  
Expense of heartworm prevention and testing was a common barrier for clients getting 
this care for their pet. Unfortunately, changing the cost of procedures and medication is not a 
feasible solution. A step that can be taken to help lower this barrier is education about the cost 
of owning a pet. Many people do not consider this expense, or veterinary expenses in general, 
when purchasing a pet. Lifelong heartworm prevention is an investment in the health and 
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longevity of a canine companion, just as any other preventative measure. In some cases, once 
clients understand how important this medication is they can justify the cost. A veterinarian is 
well versed in accommodating client budget into providing care for a patient. Simply identifying 
this barrier can go a long way in helping a pet get the best care within a budget as opposed to 
no care. Communication and education are the veterinary professionals’ only practical tools to 
combat the barrier of expense.  
Forgetfulness is perhaps the most straightforward and easy to remedy barrier. A 
monthly responsibility can be difficult to remember for clients with busy lives. Veterinary 
professionals have several options to help clients overcome this barrier to consistent 
protection. The practice can post reminders on social media, recommend putting reminders on 
smartphones and calendars, and inform clients of reminder programs. Many heartworm 
prevention manufactures offer programs that will remind clients to give prevention with a text 
or email. When clients share their struggle with forgetfulness, it is a great opportunity to 
educate them on why annual testing is so highly recommended.  
Veterinary professionals want to protect as many canine patients as possible from the 
fatal parasite dirofilaria immitis, but the only way is through client cooperation. Three main 
causes of client non-compliance have been identified to help veterinary professionals see 
where they are lacking in terms of getting patients on prevention. Many of these barriers are 
not unique to heartworm prevention but are encountered in almost every aspect of veterinary 
medicine: expense and client misunderstanding. Speaking honestly and frequently with clients 
and checking their understanding is the only way to overcome these barriers. Heartworm 
disease can be complex and difficult to understand, especially for a client, but taking the time 
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to ensure their understanding will pay off with prevention compliance and fewer patients 
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Informed Consent Document 
 
Thank you for taking the first step to participate in the undergraduate research of Emily 
Fischels! This survey will be used to investigate the use and understanding of heartworm 
prevention in dogs. Participation in this study is voluntary. You are free to leave questions blank 
or exit the survey at any time with no fear of repercussions. Please answer the questions 
honestly, there will be no judgement of answers perceived to be “right” or “wrong” by the 
investigator or involved parties. Participants will remain anonymous; no identifying information 
will be collected. However, the investigator cannot guarantee confidentiality or eliminate all 
possibility of risk through an online survey platform. 
Participation in this study may not benefit you directly, but it will help veterinarians better 
serve pets and their owners by understanding the barriers to pets receiving consistent 
heartworm prevention. 
This research is overseen by Dr. Laura Ken Hoffman assistant professor at Murray State 
University as well as Honors College Executive Director, Dr. Warren Edminster.  
If you have any questions or concerns about this study, please contact: 
Primary investigator: Emily Fischels (efischels@murraystate.edu) 

















By checking "I agree", you are acknowledging that you understand your above rights AND that 
you are 18 years of age or older. * 
I agree 
Are you the primary caretaker of at least one dog? 
Yes 
No 
Are you a student or alumni of the MSU Veterinary Technology Program or are you 
employed/formally educated in the field of veterinary medicine? 
Yes 
No 
Has your dog(s) been seen by a veterinarian in the past year? 
Yes 
No 
Is your dog(s) 6 months of age or older? 
Yes 
No 
How many dogs over the age of 6 months do you have? 
Has a veterinary professional (veterinarian, technician, receptionist, etc.) ever talked to you 
about heartworms/heartworm prevention? 
Yes 
No 
If so, which professional? 
Veterinarian 





If yes, please select the most correct answer to the following statements. 
30 
 
















If a veterinary professional has never spoken to you about heartworm prevention, were you 










































Please indicate how often oral/topical heartworm prevention SHOULD be given 
 
I strive to give my dog heartworm prevention… *either by giving monthly preventative or by 
Proheart injections given by a veterinarian* 
Year-round 
Only during the warm months of the year 
I do not give heartworm prevention 
Other: 
 
My pet actually receives heartworm prevention ___ months out of the year 
 
If your pet does not receive any heartworm prevention, why is that? 
The prevention is too expensive 
I am not aware of the need for prevention 
My dog does not go outside or goes out only to use the bathroom and therefore cannot 
contract heartworms 
I am aware of heartworms and do not believe prevention is effective 
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If your pet receives some heartworm prevention but not 12 months out of the year, why is 
that? Select all that apply 
I don’t believe it is necessary in the winter/cooler months  
I forget to give prevention 
I forget to buy prevention 
Other: 
 





If not, why is that? 
I decline the annual heartworm test 
I have never been offered a heartworm test for my dog 
My dog has not been to the vet’s office 
If you decline the annual heartworm test, please explain why 
Would you like more information about heartworms and how to protect your dog? 
Yes 
No 
Would you like to add anything? 
Please speak to your veterinarian about any questions related to your dog’s health including 
heartworms and heartworm prevention. Thank you for participating in my research! 
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